Compare FITB & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FITB | IDXX |
|---|---|---|
| Founded | 1858 | 1983 |
| Country | United States | United States |
| Employees | 18676 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2B | 43.6B |
| IPO Year | N/A | 1996 |
| Metric | FITB | IDXX |
|---|---|---|
| Price | $56.51 | $551.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | $55.13 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 7.2M | 587.1K |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $57.09 | $10.88 |
| Revenue Next Year | $7.06 | $8.59 |
| P/E Ratio | ★ $15.20 | $159.95 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $40.05 | $507.55 |
| 52 Week High | $56.59 | $769.98 |
| Indicator | FITB | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 47.27 |
| Support Level | $47.35 | $549.60 |
| Resistance Level | N/A | $587.04 |
| Average True Range (ATR) | 1.24 | 16.94 |
| MACD | 0.28 | -1.19 |
| Stochastic Oscillator | 85.63 | 29.24 |
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of March 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.